Articles from Demy-Colton

Biotech Showcase™ returns to San Francisco during J.P. Morgan Healthcare Week, marking its 19th year as a premier destination for global biopharma leaders to showcase their companies and technologies, build relationships, and make deals with venture investors and partners. Taking place January 12-14 and virtually January 21-22, the event will gather more than 1,200 life sciences investors and 3,200 global biopharma professionals including representatives from companies including PhRMA, BIO, Novo, Ipsen, Regeneron, and Sofinnova Investments.

Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 17th year with record-breaking investor and partner meetings. 6,700+ meetings facilitated in-person and online connections while more than 340 company presentations and 28 panels delivered new value to in-person attendees and helped to shape the 2025 outlook for biotechnology.

Biotechnology is set for significant transformation in 2025 with an incoming political administration, rapid scientific advancements, and the convergence of technology and biology. Understand how significant changes in regulation, R&D, and partnering trends will shape the future of your life science company. Forge the investment and partnering relationships you need and get to know more than 75 industry media at Biotech Showcase 2025, taking place during J.P. Morgan Healthcare Week. Registration and partnering are now open!

Marking its 17th year, Biotech Showcase™ will once again serve as the premier destination for global biopharma leaders to connect and advance innovation during J.P. Morgan Healthcare Week. Taking place January 13-15, 2025, in San Francisco, and virtually from January 21-22, 2025, the event will bring together more than 3,200 professionals, including over 1,200 investors, from across the life sciences industry.

Demy-Colton and EBD Group’s Biotech Showcase™, the premier investor conference for private and micro to mid-cap biotechnology companies, concluded its 16th year, bringing together over 3,400 attendees – including a record-breaking 1,285 investors and 110 members of the media.

Demy-Colton and EBD Group’s Biotech Showcase™ opens in conjunction with JPM Week, January 8-10, 2024 in San Francisco. The 3,500 person, three-day, in-person event is expected to set the tone once again for the industry for private and small-cap public life sciences companies in 2024, and to serve as a hub for participants to access a curated network of decision-makers at major companies, media and top angel and venture investors. A virtual event will follow from January 16-17.

Marking its 16th year, Biotech Showcase™, co-produced by Demy-Colton and EBD Group, will bring together more than 3,300 attendees – including more than 1,300 investors – this year in San Francisco from January 8-10, 2024 and again virtually from January 16-17, 2024.

Demy-Colton’s BioFuture™ concluded this week after bringing together hundreds of life sciences, diagnostics, pharmaceutical, health delivery and digital health pioneers – including more than 80 speakers, 150 forward-thinking investors and 50 journalists. Participants assembled in New York to weigh in on what lies ahead in healthcare and bioscience.

Demy-Colton’s BioFuture™ conference opens in just two weeks, featuring top innovators, executives and policymakers weighing in on what lies ahead in healthcare and bioscience.

This Fall, BioFuture™ will convene more than 700 therapeutic pioneers, innovators, journalists and investors – today’s BioFuturists – in candid, unfiltered conversations and in-person and virtual networking about the technologies and trends shaping the future of bioscience, digital technology and healthcare. Hosted by Demy-Colton, a leader in connecting biopharma, life science and digital health executives, this year’s conference will return to New York City’s Lotte New York Palace on October 4. The conference will feature three days of unfiltered plenary session dialog, unscripted interviews, company presentations, workshops and networking about the seismic shifts in healthcare innovation... how it’s discovered, how it’s developed and how it’s delivered.

BioFuture™, produced by Demy-Colton, welcomed over 625 attendees, over 140 investors, and 80 presenting companies. Held at the Lotte New York Palace from November 7-9 and the following week virtually, the event brought together healthcare and biotechnology leaders, investors, sector stakeholders, and bleeding-edge disruptors who are reimagining therapeutics. Among the attendees were more than 30 members of the press.

Over 500 attendees and 100 plus high-profile speakers from the biopharma and life sciences industry are slated to participate in the second-year launch of BioFuture™, a conference convening leading healthcare experts, top investors, stakeholders, and cutting-edge disruptors who are reimagining the future of therapeutics. This future-focused in-person event will take place at Lotte New York Palace from November 7-9, 2022. A virtual registration option will also be offered from November 14-16, 2022, providing scheduled one-to-one meetings and access to the event’s recorded content. The virtual features are also included as part of in-person registration.

Demy-Colton, a leader in connecting life science and digital health executives, today announced the second year launch of BioFuture™, a conference convening healthcare thinkers, top investors, stakeholders, and cutting-edge disruptors who are reimagining the future of therapeutics. Over 550 attendees and 100 plus high-profile speakers from the biopharma and life sciences industry are expected to participate in this future-focused in-person event, which will take place at Lotte New York Palace from November 7-9, 2022. BioFuture™ will also offer a virtual partnering option from November 14-16, 2022, including access to the event’s recorded content.

Demy Colton, a leader in life sciences and digital health events, today announced that its new conference BioFuture™, an in-person and virtual event held last week in New York City, attracted more than 550 attendees, including 100 speakers sharing their expertise, insight, and predictions, and over 60 innovative companies who shared their cutting-edge technologies and breakthrough advancements. The inaugural event was held at Cure by Deerfield, a new innovation campus, that helped make BioFuture a realization.

Demy-Colton, a leader in connecting life science and digital health executives, announced today the speaker list and updated panel sessions for BioFuture, a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies to “Reimagine the Future of Healthcare.” BioFuture will be held in New York City on October 5-6, 2021, at Cure, Deerfield’s vertical healthcare-dedicated innovation campus, with a virtual attendance option.

Demy-Colton, a leader in connecting life science and digital health executives, announced today the launch of BioFuture, a conference convening future-focused healthcare thinkers, top investors, stakeholders and cutting-edge companies to “Reimagine the Future of Healthcare”. BioFuture will be held in New York City on October 5-6, 2021, at Cure, Deerfield’s vertical healthcare-dedicated innovation campus, with a virtual attendance option.